These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 18596129

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Thrombospondin-2 therapy ameliorates experimental glomerulonephritis via inhibition of cell proliferation, inflammation, and TGF-beta activation.
    Daniel C, Wagner A, Hohenstein B, Hugo C.
    Am J Physiol Renal Physiol; 2009 Nov; 297(5):F1299-309. PubMed ID: 19726547
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Stimulation of soluble guanylyl cyclase inhibits mesangial cell proliferation and matrix accumulation in experimental glomerulonephritis.
    Hohenstein B, Daniel C, Wagner A, Stasch JP, Hugo C.
    Am J Physiol Renal Physiol; 2005 Apr; 288(4):F685-93. PubMed ID: 15561976
    [Abstract] [Full Text] [Related]

  • 7. Dynamic expression patterns of transforming growth factor-beta(2) and transforming growth factor-beta receptors in experimental glomerulonephritis.
    Hartner A, Hilgers KF, Bitzer M, Veelken R, Schöcklmann HO.
    J Mol Med (Berl); 2003 Jan; 81(1):32-42. PubMed ID: 12545247
    [Abstract] [Full Text] [Related]

  • 8. Thrombospondin-1 is a major activator of TGF-beta in fibrotic renal disease in the rat in vivo.
    Daniel C, Wiede J, Krutzsch HC, Ribeiro SM, Roberts DD, Murphy-Ullrich JE, Hugo C.
    Kidney Int; 2004 Feb; 65(2):459-68. PubMed ID: 14717916
    [Abstract] [Full Text] [Related]

  • 9. The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil.
    Saenz de Tejada I, Angulo J, Cuevas P, Fernández A, Moncada I, Allona A, Lledó E, Körschen HG, Niewöhner U, Haning H, Pages E, Bischoff E.
    Int J Impot Res; 2001 Oct; 13(5):282-90. PubMed ID: 11890515
    [Abstract] [Full Text] [Related]

  • 10. Differential effects of phosphodiesterase-5 inhibitors on hypoxic pulmonary vasoconstriction and pulmonary artery cytokine expression.
    Tsai BM, Turrentine MW, Sheridan BC, Wang M, Fiore AC, Brown JW, Meldrum DR.
    Ann Thorac Surg; 2006 Jan; 81(1):272-8. PubMed ID: 16368379
    [Abstract] [Full Text] [Related]

  • 11. Effects of two selective phosphodiesterase type 5 inhibitors, sildenafil and vardenafil, on object recognition memory and hippocampal cyclic GMP levels in the rat.
    Prickaerts J, van Staveren WC, Sik A, Markerink-van Ittersum M, Niewöhner U, van der Staay FJ, Blokland A, de Vente J.
    Neuroscience; 2002 Jan; 113(2):351-61. PubMed ID: 12127092
    [Abstract] [Full Text] [Related]

  • 12. A phosphodiesterase-5 inhibitor vardenafil enhances angiogenesis through a protein kinase G-dependent hypoxia-inducible factor-1/vascular endothelial growth factor pathway.
    Sahara M, Sata M, Morita T, Nakajima T, Hirata Y, Nagai R.
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1315-24. PubMed ID: 20413734
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pentoxifylline Attenuates Proteinuria in Anti-Thy1 Glomerulonephritis via Downregulation of Nuclear Factor-κB and Smad2/3 Signaling.
    Chen YM, Chiang WC, Yang Y, Lai CF, Wu KD, Lin SL.
    Mol Med; 2015 Apr 13; 21(1):276-84. PubMed ID: 25879629
    [Abstract] [Full Text] [Related]

  • 15. The effects of platelet-derived growth factor antagonism in experimental glomerulonephritis are independent of the transforming growth factor-beta system.
    Ostendorf T, Kunter U, van Roeyen C, Dooley S, Janjic N, Ruckman J, Eitner F, Floege J.
    J Am Soc Nephrol; 2002 Mar 13; 13(3):658-667. PubMed ID: 11856769
    [Abstract] [Full Text] [Related]

  • 16. Thrombospondin peptides are potent inhibitors of mesangial and glomerular endothelial cell proliferation in vitro and in vivo.
    Hugo CP, Pichler RP, Schulze-Lohoff E, Pröls F, Adler S, Krutsch HC, Murphy-Ullrich JE, Couser WG, Roberts DD, Johnson RJ.
    Kidney Int; 1999 Jun 13; 55(6):2236-49. PubMed ID: 10354272
    [Abstract] [Full Text] [Related]

  • 17. The role of PDE5 inhibitors in heme oxygenase-cGMP relationship in rat cavernous tissues.
    Aziz MT, Mostafa T, Atta H, Rashed L, Marzouk SA, Obaia EM, Sabry D, Hassouna AA, El-Shehaby AM, Aziz AT.
    J Sex Med; 2008 Jul 13; 5(7):1636-45. PubMed ID: 18208506
    [Abstract] [Full Text] [Related]

  • 18. Modulation of high affinity ATP-dependent cyclic nucleotide transporters by specific and non-specific cyclic nucleotide phosphodiesterase inhibitors.
    Aronsen L, Orvoll E, Lysaa R, Ravna AW, Sager G.
    Eur J Pharmacol; 2014 Dec 15; 745():249-53. PubMed ID: 25445042
    [Abstract] [Full Text] [Related]

  • 19. PDE5 inhibition against acute renal ischemia reperfusion injury in rats: does vardenafil offer protection?
    Kyriazis I, Kagadis GC, Kallidonis P, Georgiopoulos I, Marazioti A, Geronasiou A, Liourdi D, Loudos G, Schinas V, Apostolopoulos D, Papadaki H, Flordellis C, Nikiforidis GC, Papapetropoulos A, Liatsikos EN.
    World J Urol; 2013 Jun 15; 31(3):597-602. PubMed ID: 23143734
    [Abstract] [Full Text] [Related]

  • 20. Selective phosphodiesterase-5 inhibition reduces neointimal hyperplasia in rat carotid arteries after surgical endarterectomy.
    Hirschberg K, Radovits T, Loganathan S, Entz L, Beller CJ, Gross ML, Sandner P, Karck M, Szabó G.
    J Thorac Cardiovasc Surg; 2009 Jun 15; 137(6):1508-14. PubMed ID: 19464472
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.